blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1940373

EP1940373 - 1-FLUORO-1-DEOXY-SCYLLO-INOSITOL FOR THE TREATMENT OF ALZHEIMER'S DISEASE [Right-click to bookmark this link]
Former [2008/28]INOSITOL DERIVATIVES AND THEIR USES IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DESPOSITION, ACCUMULATION OR PERSISTENCE
[2014/47]
StatusNo opposition filed within time limit
Status updated on  11.03.2016
Database last updated on 07.10.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): CY, HU, NL, SE, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Waratah Pharmaceuticals, Inc.
101 College Street Suite 220
Toronto, ON M5G 1L7 / CA
[2008/28]
Inventor(s)01 / CRUZ, Antonio
89 Dunloe Road
Toronto, Ontario M5P 2T7 / CA
02 / KURDYDYK, Linda
215 St. Clements
Toronto, Ontario M4R 1H3 / CA
 [2008/28]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2015/19]Holliday, Louise Caroline, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Former [2008/28]Holliday, Louise Caroline, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date06850456.213.10.2006
[2008/28]
WO2006IB04181
Priority number, dateUS20050725634P13.10.2005         Original published format: US 725634 P
[2008/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007119108
Date:25.10.2007
Language:EN
[2007/43]
Type: A2 Application without search report 
No.:EP1940373
Date:09.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 25.10.2007 takes the place of the publication of the European patent application.
[2008/28]
Type: B1 Patent specification 
No.:EP1940373
Date:06.05.2015
Language:EN
[2015/19]
Type: B8 Corrected title page of specification 
No.:EP1940373
Date:24.06.2015
[2015/26]
Search report(s)International search report - published on:CA13.03.2008
(Supplementary) European search report - dispatched on:EP29.04.2009
ClassificationIPC:A61K31/045, A61K31/047, A61K31/075, A61P25/28
[2009/22]
CPC:
A61K31/045 (EP,US); C07C55/28 (US); A61K31/047 (EP,US);
A61K31/075 (EP,US); A61K31/16 (EP,US); A61K31/66 (EP,US);
A61P1/04 (EP); A61P1/14 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P21/00 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/20 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/26 (EP); A61P25/28 (EP); A61P25/32 (EP);
A61P25/36 (EP); A61P29/00 (EP); A61P29/02 (EP);
A61P3/02 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/06 (EP);
A61P31/08 (EP); A61P31/10 (EP); A61P31/12 (EP);
A61P31/18 (EP); A61P31/22 (EP); A61P33/02 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P7/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); A61P9/14 (EP); C07C43/196 (US);
Y02A50/30 (EP) (-)
Former IPC [2008/28]A61K31/075, A23L1/30, A61K31/047, A61P25/28, A61K31/045
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/19]
Former [2008/28]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:1-FLUORO-1-DEOXY-SCYLLO-INOSITOL ZUR BEHANDLUNG VON ALZHEIMER'SCHE KRANKHEIT[2014/47]
English:1-FLUORO-1-DEOXY-SCYLLO-INOSITOL FOR THE TREATMENT OF ALZHEIMER'S DISEASE[2014/47]
French:1-FLUORO-1-DEOXY-SCYLLO-INOSITOL DESTINE AU TRAITEMENT DE LA MALADIE D'ALZHEIMER[2014/47]
Former [2008/28]INOSITOL-DERIVATE UND IHRE VERWENDUNGEN BEI DER BEHANDLUNG VON ERKRANKUNGEN, DIE DURCH ABNORMALE PROTEINFALTUNG ODER AGGREGATION ODER AMYLOID-BILDUNG, ABSCHEIDUNG, AKKUMULATION ODER PERSISTENZ GEKENNZEICHNET SIND
Former [2008/28]INOSITOL DERIVATIVES AND THEIR USES IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DESPOSITION, ACCUMULATION OR PERSISTENCE
Former [2008/28]DERIVES DE L'INOSITOL ET LEURS UTILISATIONS POUR TRAITER DES MALADIES CARACTÉRISÉES PAR UN REPLIEMENT PROTÉIQUE ANORMAL, UNE AGRÉGATION PROTÉIQUE, OU UNE FORMATION, UN DÉPÔT, UNE ACCUMULATION OU UNE PERSISTANCE D'AMYLOÏDE
Entry into regional phase12.05.2008National basic fee paid 
12.05.2008Search fee paid 
12.05.2008Designation fee(s) paid 
12.05.2008Examination fee paid 
Examination procedure12.05.2008Examination requested  [2008/28]
28.07.2009Amendment by applicant (claims and/or description)
31.01.2012Despatch of a communication from the examining division (Time limit: M04)
18.07.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
30.08.2012Reply to a communication from the examining division
18.03.2013Despatch of a communication from the examining division (Time limit: M04)
20.06.2013Reply to a communication from the examining division
26.11.2014Communication of intention to grant the patent
02.03.2015Receipt of the translation of the claim(s)
26.03.2015Fee for grant paid
26.03.2015Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.01.2012
Opposition(s)09.02.2016No opposition filed within time limit [2016/15]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
03.09.2012Request for further processing filed
03.09.2012Full payment received (date of receipt of payment)
Request granted
02.10.2012Decision despatched
Fees paidRenewal fee
27.10.2008Renewal fee patent year 03
13.10.2009Renewal fee patent year 04
12.10.2010Renewal fee patent year 05
11.10.2011Renewal fee patent year 06
11.10.2012Renewal fee patent year 07
14.10.2013Renewal fee patent year 08
14.10.2014Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.10.2006
AT06.05.2015
BE06.05.2015
CY06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
MC06.05.2015
NL06.05.2015
PL06.05.2015
RO06.05.2015
SE06.05.2015
SI06.05.2015
SK06.05.2015
TR06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
GB13.10.2015
IE13.10.2015
LU13.10.2015
CH31.10.2015
LI31.10.2015
FR02.11.2015
[2017/39]
Former [2016/45]AT06.05.2015
BE06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
MC06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
GB13.10.2015
IE13.10.2015
LU13.10.2015
CH31.10.2015
LI31.10.2015
FR02.11.2015
Former [2016/36]AT06.05.2015
BE06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
MC06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
GB13.10.2015
LU13.10.2015
CH31.10.2015
LI31.10.2015
FR02.11.2015
Former [2016/34]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
MC06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
GB13.10.2015
LU13.10.2015
CH31.10.2015
LI31.10.2015
Former [2016/33]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
MC06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
LU13.10.2015
CH31.10.2015
LI31.10.2015
Former [2016/28]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
MC06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
LU13.10.2015
Former [2016/26]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
LU13.10.2015
Former [2016/24]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
PL06.05.2015
RO06.05.2015
SI06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2016/21]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
IT06.05.2015
LT06.05.2015
LV06.05.2015
PL06.05.2015
RO06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2016/10]AT06.05.2015
CZ06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
LT06.05.2015
LV06.05.2015
PL06.05.2015
RO06.05.2015
SK06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2016/09]AT06.05.2015
DK06.05.2015
EE06.05.2015
ES06.05.2015
FI06.05.2015
LT06.05.2015
LV06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2016/07]AT06.05.2015
DK06.05.2015
ES06.05.2015
FI06.05.2015
LT06.05.2015
LV06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2015/51]AT06.05.2015
ES06.05.2015
FI06.05.2015
LT06.05.2015
LV06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2015/50]ES06.05.2015
FI06.05.2015
LT06.05.2015
LV06.05.2015
BG06.08.2015
GR07.08.2015
IS06.09.2015
PT07.09.2015
Former [2015/49]ES06.05.2015
FI06.05.2015
LT06.05.2015
LV06.05.2015
GR07.08.2015
PT07.09.2015
Documents cited:Search[PXL]WO2007041855  (WARATAH PHARMACEUTICALS INC [CA], et al) [PXL] 1-24 * abstract * * L: Priority * * page 1, line 12 - page 6, line 20 ** claims 1-50 *;
 [PXL]WO2007134449  (WARATAH PHARMACEUTICALS INC [CA], et al) [PXL] 1-24 * abstract * * L: Priority * * page 1, line 23 - line 25 * * page 22, line 28 - page 34, line 22 * * claim 27 *
International search[X]CA2214635  (UNIV WASHINGTON [US]);
 [X]CA2486663  (CHOMCZYNSKI PIOTR [US]);
 [X]WO2004075882  (ELLIPSIS BIOTHERAPEUTICS CORP [CA], et al);
 [XP]WO2006053428  (MCLAURIN JOANNE [CA])
Examination   - SUN Y ET AL, "Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 16, no. 15, doi:10.1016/J.BMC.2008.06.045, ISSN 0968-0896, (20080801), pages 7177 - 7184, (20080626), XP023610694

DOI:   http://dx.doi.org/10.1016/j.bmc.2008.06.045
by applicantWO2004075882
    - BOUVEAULT L. BULL., LA SOCIETE CHIMIQUE PARIS, (1894), vol. 11, pages 44 - 147
    - MICHAELIS T ET AL., NMR IN BIOMEDICIEN, (1993), vol. 6, pages 105 - 109
    - S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, (1977), vol. 66, page 1
    - FIESER; FIESER'S, Reagents for Organic Synthesis, JOHN WILEY AND SONS, (1991), pages 1 - 17
    - Rodd's Chemistry of Carbon Compounds, ELSEVIER SCIENCE PUBLISHERS, (1989), vol. 1-5
    - Organic Reactions, JOHN WILEY AND SONS, (1991), vol. 1- 40
    - MARCH J., Advanced Organic Chemistry, 4th ed., JOHN WILEY AND SONS
    - HUSSON, C., CARBOHYRATE RESEARCH, (1998), vol. 307, pages 163 - 165
    - SARMAH, M.P.; SHASHIDAR, M.S., CARBOHYDRATE RESEARCH, (2003), vol. 338, pages 999 - 1001
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY
    - CHISHTI, M. A., J.BIOL CHEM, (2001), vol. 276, pages 21562 - 21570
    - JANUS,C., NATURE, (2000), vol. 408, pages 979 - 982
    - WILTFANG, J. ET AL., J NEUROCHEM, (2002), vol. 81, pages 481 - 496
    - HACCOU, P.; MELLIS, E., Statistical Analysis of Behavioural Data, OXFORD UNIVERSITY PRESS, (1995), pages 120 - 186
    - CHISHTI, M. A. ET AL., J. BIOL CHEM, (2001), vol. 276, pages 21562 - 21570
    - JANUS,C. ET AL., NATURE, (2000), vol. 408, pages 979 - 982
    - O'HARE, E. ET AL., BEHAVIOR PHARMACOLOGY, (1996), vol. 7, pages 742 - 753
    - RICHARDSON, RL ET AL., BRAIN RESEARCH, (2002), vol. 54, pages 1 - 10
    - KHETERPAL, I ET AL., BIOCHEMISTRY, (2001), vol. 40, no. 39, page 11757
    - CANNON MJ ET AL., ANAL BIOCHEM., (2004), vol. 328, no. 1, page 67
    - LETICIA TOLEDO-SHERMAN ET AL., J. MED. CHEM., (2005), vol. 48, page 3221
    - SLON-USAKIEWICZ J.J. ET AL., CLIN. PROTEOM. J., (2004), vol. 1, pages 227 - 234
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.